Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | 1lambda~6~,2,6-Thiadiazine-1,1(2H)-dione | HCID 15632699 | — |
| Reactant | 4-[4-(2-Bromoethyl)piperidin-1-yl]-6,7-dimethoxyquinazoline | HCID 20434882 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 20434952 | HCID 20434952 | — |
Reaction Steps
Sodium hydride (0.19 g. of a 50% dispersion in oil) was added to a stirred solution of 2H-1,2,6-thiadiazine-1,1-dioxide (0.52 g) in dimethylformamide (4 cm3). After 0.5 hours 1-(6.7-dimethoxyquinazolin-4-yl)-4-(2-bromoethyl)piperidine (0.60 g) was added and the mixture was warmed at 70° for 10 hours. The solvent was removed in vacuo, water was added and the mixture was extracted with chloroform (4×20 cm3). The dried (MgSO4) extracts were evaporated and the residue was chromatographed on silica (Merck 60. 9385) eluting with methanol:ethyl acetate, 1:19, to give an oil which was crystallised from ethyl acetate to afford 1-(6,7-dimethoxyquinazolin-4-yl)-4-[2-(1,1-dioxo-1,2,6-thiadiazin-2-yl)ethyl]piperidine as microcrystals, m.p. 176°-8°, (0.18 g).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04489075 |
|---|
| Source dataset | uspto-grants-1984_12 |
|---|
| ORD ID | ord-a9713af738994d63838183ff6bfca1c3 |
|---|
| Source note | uspto-grants-1984_12 |
|---|